Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 6 | 2026 | 350 | 1.530 |
Why?
|
| Brain Neoplasms | 6 | 2026 | 1300 | 1.030 |
Why?
|
| Spermidine | 1 | 2024 | 18 | 0.880 |
Why?
|
| Taste | 6 | 2025 | 235 | 0.750 |
Why?
|
| Tumor Microenvironment | 3 | 2026 | 732 | 0.710 |
Why?
|
| Salivary Proteins and Peptides | 4 | 2025 | 15 | 0.700 |
Why?
|
| Quinine | 5 | 2025 | 21 | 0.680 |
Why?
|
| Flavoring Agents | 1 | 2020 | 13 | 0.660 |
Why?
|
| Food Preferences | 1 | 2020 | 125 | 0.600 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 928 | 0.590 |
Why?
|
| Rats, Long-Evans | 4 | 2020 | 122 | 0.270 |
Why?
|
| Sucrose | 4 | 2020 | 111 | 0.270 |
Why?
|
| Amnion | 2 | 2024 | 28 | 0.260 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2025 | 2 | 0.240 |
Why?
|
| Lipocalin-2 | 1 | 2026 | 80 | 0.230 |
Why?
|
| Connexin 43 | 1 | 2025 | 35 | 0.230 |
Why?
|
| Ornithine Decarboxylase | 1 | 2024 | 13 | 0.220 |
Why?
|
| Pituitary-Adrenal System | 1 | 2026 | 165 | 0.220 |
Why?
|
| Rats | 7 | 2025 | 5610 | 0.220 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2026 | 198 | 0.220 |
Why?
|
| Androgens | 1 | 2026 | 194 | 0.220 |
Why?
|
| Varicose Ulcer | 1 | 2024 | 4 | 0.210 |
Why?
|
| Wound Healing | 2 | 2024 | 357 | 0.210 |
Why?
|
| Neoplastic Stem Cells | 2 | 2025 | 414 | 0.210 |
Why?
|
| Tannins | 2 | 2025 | 6 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 167 | 0.210 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2026 | 227 | 0.210 |
Why?
|
| Diabetic Foot | 1 | 2024 | 24 | 0.210 |
Why?
|
| Olfactory Perception | 1 | 2023 | 16 | 0.200 |
Why?
|
| Animals | 14 | 2026 | 38010 | 0.200 |
Why?
|
| Cell Line, Tumor | 3 | 2026 | 3611 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2026 | 626 | 0.190 |
Why?
|
| Diet | 3 | 2025 | 1290 | 0.180 |
Why?
|
| Touch | 1 | 2021 | 38 | 0.180 |
Why?
|
| Self-Help Devices | 1 | 2021 | 24 | 0.180 |
Why?
|
| Mice | 8 | 2026 | 18378 | 0.180 |
Why?
|
| Behavior, Animal | 3 | 2020 | 516 | 0.180 |
Why?
|
| Taste Buds | 1 | 2020 | 209 | 0.130 |
Why?
|
| Temperature | 1 | 2020 | 676 | 0.130 |
Why?
|
| Orexin Receptors | 1 | 2016 | 5 | 0.130 |
Why?
|
| Appetite Regulation | 1 | 2016 | 32 | 0.120 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 81 | 0.120 |
Why?
|
| Ventral Tegmental Area | 1 | 2016 | 60 | 0.120 |
Why?
|
| Male | 10 | 2026 | 71501 | 0.110 |
Why?
|
| Eating | 1 | 2016 | 397 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2026 | 6043 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2019 | 688 | 0.100 |
Why?
|
| Immunotherapy | 2 | 2023 | 659 | 0.070 |
Why?
|
| Castration | 1 | 2026 | 15 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2026 | 2026 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2026 | 76 | 0.060 |
Why?
|
| Humans | 8 | 2026 | 143560 | 0.060 |
Why?
|
| Female | 5 | 2026 | 77252 | 0.060 |
Why?
|
| TRPM Cation Channels | 1 | 2025 | 75 | 0.060 |
Why?
|
| Gap Junctions | 1 | 2025 | 64 | 0.060 |
Why?
|
| Inflammasomes | 1 | 2026 | 146 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2026 | 710 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2026 | 392 | 0.050 |
Why?
|
| Microglia | 1 | 2026 | 257 | 0.050 |
Why?
|
| Methylamines | 1 | 2023 | 40 | 0.050 |
Why?
|
| Immunity | 1 | 2023 | 138 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2025 | 863 | 0.050 |
Why?
|
| Choline | 1 | 2023 | 133 | 0.050 |
Why?
|
| Testosterone | 1 | 2026 | 423 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2025 | 5214 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2026 | 537 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2026 | 1781 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2026 | 1226 | 0.040 |
Why?
|
| Feedback | 1 | 2021 | 180 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 29 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2020 | 28 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2020 | 47 | 0.040 |
Why?
|
| Solitary Nucleus | 1 | 2020 | 23 | 0.040 |
Why?
|
| Taste Perception | 1 | 2020 | 31 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 2531 | 0.040 |
Why?
|
| Propylthiouracil | 1 | 2019 | 6 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2019 | 49 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2021 | 175 | 0.040 |
Why?
|
| Stimulation, Chemical | 1 | 2019 | 58 | 0.040 |
Why?
|
| Equipment Design | 1 | 2021 | 533 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2019 | 52 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 370 | 0.040 |
Why?
|
| Isoproterenol | 1 | 2019 | 101 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3109 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2020 | 248 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2542 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 392 | 0.030 |
Why?
|
| Phenotype | 1 | 2025 | 3211 | 0.030 |
Why?
|
| Bacteria | 1 | 2023 | 888 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 16740 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 2056 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 454 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 4182 | 0.020 |
Why?
|
| Quality of Life | 1 | 2024 | 3080 | 0.020 |
Why?
|
| Motivation | 1 | 2016 | 609 | 0.020 |
Why?
|